Brian Christopher Raudenbush
6Patents
5h-index
43Co-inventors
55Inventor score
Filing activity: Feb 27, 2004 → Mar 8, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7879873B2 | Azaindazole compounds as CCR1 receptor antagonists | Human Necessities | 15 | Active |
| US7557129B2 | Cyanopyridine derivatives useful in the treatment of cancer and other disorders | Chemistry; Metallurgy | 14 | Expired |
| US8063065B2 | Azaindazole compounds as CCR1 receptor antagonists | Human Necessities | 10 | Active |
| US8076488B2 | Bicyclic urea derivatives useful in the treatment of cancer and other disorders | Chemistry; Metallurgy | 8 | Expired |
| US8293917B2 | Pyrazole compounds as CCR1 antagonists | Chemistry; Metallurgy | 7 | Active |
| US8569339B2 | Soluble guanylate cyclase activators | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.